Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered… https://t.co/cZ13M2gPJk
    about 18 hours ago
  • New post on Science and Enterprise: Biotech Creating More Efficient Crispr Therapies https://t.co/JAfb7hBMoH #Science #Business
    about 18 hours ago
  • I have a Mode joke. It was a Moderna joke, but a messenger lost the RNA.
    about 2 days ago
  • Behind the scenes, CEPI and BARDA were funding vaccine development and covering manufacturing costs. They helped ge… https://t.co/4F5vMbVsrK
    about 3 days ago
  • A YouGov survey taken earlier this month indicates the U.S. public largely supports rejoining the Paris climate agr… https://t.co/eJd2v8G7K8
    about 3 days ago

Please share Science & Enterprise

Infographic – Global Climate Technology Hubs

Chart: climate tech hubs

The report also highlights where the investments were made, with the geographic hubs or clusters attracting the most investments, this weekend’s infographic. . . . → Read More: Infographic – Global Climate Technology Hubs

Biotechs, Univ. Labs Partner on Covid-19 Combo Therapy

Lab mouse

Two biotechnology companies are developing a Covid-19 treatment that combines engineered antibodies and natural killer immune system cells. . . . → Read More: Biotechs, Univ. Labs Partner on Covid-19 Combo Therapy

Glove-App System Translates Sign Language to Speech

Sign language translation glove

University engineers designed a glove with electronic sensors that sends signals to a smartphone app to translate American Sign Language into audible speech. . . . → Read More: Glove-App System Translates Sign Language to Speech

Covid-19 Vaccine for Lower-Income Regions Underway

Robin Shattock

Researchers in the U.K. designed a vaccine to prevent Covid-19 infections and is starting an enterprise to make it available to lower-income countries. . . . → Read More: Covid-19 Vaccine for Lower-Income Regions Underway

Industry, Univ. Labs Partner on Covid-19 Therapy

Covid-19 illustration

Researchers from industry and academic labs are developing a synthetic antibody that in lab tests shows promise as both a Covid-19 therapy and vaccine. . . . → Read More: Industry, Univ. Labs Partner on Covid-19 Therapy

Five Covid-19 Vaccines in Clinical Trials

Coronavirus face mask

A review of vaccines for preventing Covid-19 infections shows five of those projects are in early-stage clinical trials, with 18 more in preclinical stage. . . . → Read More: Five Covid-19 Vaccines in Clinical Trials

Case Study Maps Covid-19 Immune Response

Coronavirus

Infectious disease specialists in Australia tracked the course of an early patient’s immune-system response to non-severe novel coronavirus, or Covid-19, infections. . . . → Read More: Case Study Maps Covid-19 Immune Response

Trial Testing Arthritis Drug as Covid-19 Treatment

Covid-19 illustration

A clinical trial is enrolling patients with severe novel coronavirus infections to test a synthetic antibody now approved to treat rheumatoid arthritis. . . . → Read More: Trial Testing Arthritis Drug as Covid-19 Treatment

Janssen, BARDA Partner on Coronavirus Vaccine

Coronavirus

An industry-government collaboration aims to advance and produce vaccines against the 2019 novel coronavirus outbreak in China and elsewhere. . . . → Read More: Janssen, BARDA Partner on Coronavirus Vaccine

Intl Group Calls for More Coronavirus Vaccines

Hong Kong residents in masks

An international consortium issued a proposal call for more vaccines to protect against the novel coronavirus now spreading from China to the rest of the world. . . . → Read More: Intl Group Calls for More Coronavirus Vaccines